Home > > > > Report Detail

Global Vaccines Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 07-Oct-2022
No. of pages: 95
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Vaccines Delivery companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Vaccines Delivery market. Further, it explains the major drivers and regional dynamics of the global Vaccines Delivery market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Becton Dickinson and Company (BD)

- BioCSL

- Novavax Inc.

- Vaxart Inc.

- Vaxxas

- Echo Therapeutics

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Vaccines Delivery Segment by Type

- Biological Vector

- Chemical Carrier

- Others

Vaccines Delivery Segment by Application

- Hospital

- Clinic

- Research Center

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Vaccines Delivery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Vaccines Delivery market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Vaccines Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Vaccines Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccines Delivery revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Vaccines Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Vaccines Delivery revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Becton Dickinson and Company (BD), BioCSL, Novavax Inc., Vaxart Inc., Vaxxas and Echo Therapeutics, etc.

Global Vaccines Delivery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccines Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Biological Vector
1.2.3 Chemical Carrier
1.2.4 Others
1.3 Market by Application
1.3.1 Global Vaccines Delivery Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Vaccines Delivery Market Size (2017-2028)
2.2 Vaccines Delivery Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Vaccines Delivery Market Size by Region (2017-2022)
2.4 Global Vaccines Delivery Market Size Forecast by Region (2023-2028)
2.5 Global Top Vaccines Delivery Countries Ranking by Market Size
3 Vaccines Delivery Competitive by Company
3.1 Global Vaccines Delivery Revenue by Players
3.1.1 Global Vaccines Delivery Revenue by Players (2017-2022)
3.1.2 Global Vaccines Delivery Market Share by Players (2017-2022)
3.2 Global Vaccines Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Vaccines Delivery Revenue
3.4 Global Vaccines Delivery Market Concentration Ratio
3.4.1 Global Vaccines Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccines Delivery Revenue in 2021
3.5 Global Vaccines Delivery Key Players Head office and Area Served
3.6 Key Players Vaccines Delivery Product Solution and Service
3.7 Date of Enter into Vaccines Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Vaccines Delivery Breakdown Data by Type
4.1 Global Vaccines Delivery Historic Revenue by Type (2017-2022)
4.2 Global Vaccines Delivery Forecasted Revenue by Type (2023-2028)
5 Global Vaccines Delivery Breakdown Data by Application
5.1 Global Vaccines Delivery Historic Market Size by Application (2017-2022)
5.2 Global Vaccines Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Vaccines Delivery Revenue by Company (2020-2022)
6.2 North America Vaccines Delivery Revenue by Type (2017-2028)
6.3 North America Vaccines Delivery Revenue by Application (2017-2028)
6.4 North America Vaccines Delivery Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Vaccines Delivery Revenue by Company (2020-2022)
7.2 Europe Vaccines Delivery Revenue by Type (2017-2028)
7.3 Europe Vaccines Delivery Revenue by Application (2017-2028)
7.4 Europe Vaccines Delivery Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccines Delivery Revenue by Company (2020-2022)
8.2 Asia Pacific Vaccines Delivery Revenue by Type (2017-2028)
8.3 Asia Pacific Vaccines Delivery Revenue by Application (2017-2028)
8.4 Asia Pacific Vaccines Delivery Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Vaccines Delivery Revenue by Company (2020-2022)
9.2 Latin America Vaccines Delivery Revenue by Type (2017-2028)
9.3 Latin America Vaccines Delivery Revenue by Application (2017-2028)
9.4 Latin America Vaccines Delivery Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccines Delivery Revenue by Company (2020-2022)
10.2 Middle East and Africa Vaccines Delivery Revenue by Type (2017-2028)
10.3 Middle East and Africa Vaccines Delivery Revenue by Application (2017-2028)
10.4 Middle East and Africa Vaccines Delivery Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Becton Dickinson and Company (BD)
11.1.1 Becton Dickinson and Company (BD) Company Details
11.1.2 Becton Dickinson and Company (BD) Business Overview
11.1.3 Becton Dickinson and Company (BD) Vaccines Delivery Products and Services
11.1.4 Becton Dickinson and Company (BD) Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022)
11.1.5 Becton Dickinson and Company (BD) Vaccines Delivery SWOT Analysis
11.1.6 Becton Dickinson and Company (BD) Recent Developments
11.2 BioCSL
11.2.1 BioCSL Company Details
11.2.2 BioCSL Business Overview
11.2.3 BioCSL Vaccines Delivery Products and Services
11.2.4 BioCSL Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022)
11.2.5 BioCSL Vaccines Delivery SWOT Analysis
11.2.6 BioCSL Recent Developments
11.3 Novavax Inc.
11.3.1 Novavax Inc. Company Details
11.3.2 Novavax Inc. Business Overview
11.3.3 Novavax Inc. Vaccines Delivery Products and Services
11.3.4 Novavax Inc. Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022)
11.3.5 Novavax Inc. Vaccines Delivery SWOT Analysis
11.3.6 Novavax Inc. Recent Developments
11.4 Vaxart Inc.
11.4.1 Vaxart Inc. Company Details
11.4.2 Vaxart Inc. Business Overview
11.4.3 Vaxart Inc. Vaccines Delivery Products and Services
11.4.4 Vaxart Inc. Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022)
11.4.5 Vaxart Inc. Vaccines Delivery SWOT Analysis
11.4.6 Vaxart Inc. Recent Developments
11.5 Vaxxas
11.5.1 Vaxxas Company Details
11.5.2 Vaxxas Business Overview
11.5.3 Vaxxas Vaccines Delivery Products and Services
11.5.4 Vaxxas Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022)
11.5.5 Vaxxas Vaccines Delivery SWOT Analysis
11.5.6 Vaxxas Recent Developments
11.6 Echo Therapeutics
11.6.1 Echo Therapeutics Company Details
11.6.2 Echo Therapeutics Business Overview
11.6.3 Echo Therapeutics Vaccines Delivery Products and Services
11.6.4 Echo Therapeutics Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022)
11.6.5 Echo Therapeutics Vaccines Delivery SWOT Analysis
11.6.6 Echo Therapeutics Recent Developments
12 Vaccines Delivery Market Dynamics
12.1 Vaccines Delivery Market Trends
12.2 Vaccines Delivery Market Drivers
12.3 Vaccines Delivery Market Challenges
12.4 Vaccines Delivery Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Vaccines Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Biological Vector
Table 3. Key Players of Chemical Carrier
Table 4. Key Players of Others
Table 5. Global Vaccines Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Vaccines Delivery Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Vaccines Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Vaccines Delivery Revenue Market Share by Region (2017-2022)
Table 9. Global Vaccines Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Vaccines Delivery Market Share by Players (2017-2022)
Table 11. Global Top Vaccines Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines Delivery as of 2021)
Table 12. Ranking of Global Top Vaccines Delivery Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Vaccines Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Vaccines Delivery Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Vaccines Delivery Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Vaccines Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Vaccines Delivery Revenue Market Share by Type (2017-2022)
Table 20. Global Vaccines Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Vaccines Delivery Revenue Market Share by Type (2023-2028)
Table 22. Global Vaccines Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Vaccines Delivery Revenue Market Share by Application (2017-2022)
Table 24. Global Vaccines Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Vaccines Delivery Revenue Market Share by Application (2023-2028)
Table 26. North America Vaccines Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Vaccines Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Vaccines Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Vaccines Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Vaccines Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Vaccines Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Vaccines Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Vaccines Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Vaccines Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Vaccines Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Vaccines Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Vaccines Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Vaccines Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Vaccines Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Vaccines Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Vaccines Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Vaccines Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Vaccines Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Vaccines Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Vaccines Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Vaccines Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Vaccines Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Vaccines Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Vaccines Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Vaccines Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Vaccines Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Vaccines Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Vaccines Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Vaccines Delivery Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Vaccines Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Vaccines Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Vaccines Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Vaccines Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Vaccines Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Vaccines Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 61. Becton Dickinson and Company (BD) Company Details
Table 62. Becton Dickinson and Company (BD) Business Overview
Table 63. Becton Dickinson and Company (BD) Vaccines Delivery Product and Services
Table 64. Becton Dickinson and Company (BD) Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022) & (US$ Million)
Table 65. Becton Dickinson and Company (BD) Vaccines Delivery SWOT Analysis
Table 66. Becton Dickinson and Company (BD) Recent Developments
Table 67. BioCSL Company Details
Table 68. BioCSL Business Overview
Table 69. BioCSL Vaccines Delivery Product and Services
Table 70. BioCSL Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022) & (US$ Million)
Table 71. BioCSL Vaccines Delivery SWOT Analysis
Table 72. BioCSL Recent Developments
Table 73. Novavax Inc. Company Details
Table 74. Novavax Inc. Business Overview
Table 75. Novavax Inc. Vaccines Delivery Product and Services
Table 76. Novavax Inc. Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022) & (US$ Million)
Table 77. Novavax Inc. Vaccines Delivery SWOT Analysis
Table 78. Novavax Inc. Recent Developments
Table 79. Vaxart Inc. Company Details
Table 80. Vaxart Inc. Business Overview
Table 81. Vaxart Inc. Vaccines Delivery Product and Services
Table 82. Vaxart Inc. Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022) & (US$ Million)
Table 83. Vaxart Inc. Vaccines Delivery SWOT Analysis
Table 84. Vaxart Inc. Recent Developments
Table 85. Vaxxas Company Details
Table 86. Vaxxas Business Overview
Table 87. Vaxxas Vaccines Delivery Product and Services
Table 88. Vaxxas Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022) & (US$ Million)
Table 89. Vaxxas Vaccines Delivery SWOT Analysis
Table 90. Vaxxas Recent Developments
Table 91. Echo Therapeutics Company Details
Table 92. Echo Therapeutics Business Overview
Table 93. Echo Therapeutics Vaccines Delivery Product and Services
Table 94. Echo Therapeutics Vaccines Delivery Revenue in Vaccines Delivery Business (2017-2022) & (US$ Million)
Table 95. Echo Therapeutics Vaccines Delivery SWOT Analysis
Table 96. Echo Therapeutics Recent Developments
Table 97. Vaccines Delivery Market Trends
Table 98. Vaccines Delivery Market Drivers
Table 99. Vaccines Delivery Market Challenges
Table 100. Vaccines Delivery Market Restraints
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccines Delivery Sales Market Share by Type: 2021 VS 2028
Figure 2. Biological Vector Features
Figure 3. Chemical Carrier Features
Figure 4. Others Features
Figure 5. Global Vaccines Delivery Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Center Case Studies
Figure 9. Vaccines Delivery Report Years Considered
Figure 10. Global Vaccines Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Vaccines Delivery Market Size 2017-2028 (US$ Million)
Figure 12. Global Vaccines Delivery Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Vaccines Delivery Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Vaccines Delivery Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Vaccines Delivery Market Share by Players in 2021
Figure 16. Global Top Vaccines Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines Delivery as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Vaccines Delivery Revenue in 2021
Figure 18. North America Vaccines Delivery Revenue Market Share by Company in 2021
Figure 19. North America Vaccines Delivery Revenue Market Share by Type (2017-2028)
Figure 20. North America Vaccines Delivery Revenue Market Share by Application (2017-2028)
Figure 21. North America Vaccines Delivery Revenue Share by Country (2017-2028)
Figure 22. U.S. Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Vaccines Delivery Revenue Market Share by Company in 2021
Figure 25. Europe Vaccines Delivery Revenue Market Share by Type (2017-2028)
Figure 26. Europe Vaccines Delivery Revenue Market Share by Application (2017-2028)
Figure 27. Europe Vaccines Delivery Revenue Share by Country (2017-2028)
Figure 28. Germany Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 29. France Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Vaccines Delivery Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Vaccines Delivery Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Vaccines Delivery Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Vaccines Delivery Revenue Share by Region (2017-2028)
Figure 37. China Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 40. India Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Vaccines Delivery Revenue Market Share by Company in 2021
Figure 49. Latin America Vaccines Delivery Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Vaccines Delivery Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Vaccines Delivery Revenue Share by Country (2017-2028)
Figure 52. Mexico Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Vaccines Delivery Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Vaccines Delivery Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Vaccines Delivery Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Vaccines Delivery Revenue Share by Country (2017-2028)
Figure 59. Turkey Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Vaccines Delivery Revenue (2017-2028) & (US$ Million)
Figure 62. Becton Dickinson and Company (BD) Revenue Growth Rate in Vaccines Delivery Business (2017-2022)
Figure 63. BioCSL Revenue Growth Rate in Vaccines Delivery Business (2017-2022)
Figure 64. Novavax Inc. Revenue Growth Rate in Vaccines Delivery Business (2017-2022)
Figure 65. Vaxart Inc. Revenue Growth Rate in Vaccines Delivery Business (2017-2022)
Figure 66. Vaxxas Revenue Growth Rate in Vaccines Delivery Business (2017-2022)
Figure 67. Echo Therapeutics Revenue Growth Rate in Vaccines Delivery Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global Gold Nanoparticles Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121
    Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
  • Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Gold Nanoparticles Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
  • Global Liposome Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
  • Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
  • Global Liposomes Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
  • Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129
    According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
  • Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs